Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fisiocrem Joint Ease is a topical over-the-counter analgesic cream/gel developed by Fisiocrem International for the temporary relief of symptoms associated with mild osteoarthritis, mild arthritis, and mild joint pain. The formulation is based on the Fisiocrem Solugel base and is enhanced with additional botanical active ingredients, specifically *Boswellia serrata* sap concentrated resin extract and *Nigella sativa* (black cumin) seed oil. Other key components include menthol, *Arnica montana*, *Calendula officinalis*, *Hypericum perforatum* (St. John's Wort), and *Melaleuca alternifolia* (tea tree) oil. The product works through the combined anti-inflammatory and analgesic properties of these naturally-derived ingredients to reduce joint inflammation and stiffness while promoting mobility. It is designed as a non-greasy, low-odour, non-heat formulation suitable for ongoing joint comfort and is available in various formats including tubes and pump bottles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fisiocrem Joint Ease.